Crinetics Pharmaceuticals's total assets for Q4 2025 were $1.14B, a decrease of -5.06% from the previous quarter. CRNX total liabilities were $143.41M for the fiscal quarter, a 15.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.